Dra. Ingrid Johana Gil Serrano

Institutions of which it is part

Sóc metge especialista en Al·lergologia. Actualment desenvolupo la meva activitat assistencial a l’hospital i com a investigadora Pre-Doctoral a Vall d'Hebron Institut de Recerca (VHIR). Entre les malalties al·lèrgiques tinc especial interès en l’angioedema, anafilaxi, urticària i al·lèrgia a medicaments.


Sóc metge i cirurgiana de la Universitat del Rosari de Colòmbia (2006-2012).
Especialista en Al·lergologia via MIR (2015-2019) a l'Hospital Universitari Vall d'Hebron. Actualment estic cursant el Doctorat en Medicina a la UAB, desenvolupant la meva tesi doctoral en l'estudi de biomarcadors en Angioedema.
He rebut beca de recerca de la societat catalana d'Al·lergologia i Immunologia Clínica (SCAIC) per a investigació. Participo com subinvestigadora en diversos assaigs clínics a l'Hospital Vall d'Hebron. He presentat pòsters i comunicacions orals en congressos nacionals i europeus, obtenint diversos reconeixements.
Ingrid Johana Gil Serrano


Vall Hebron Institut de Recerca

Main researcher

Translational Immunology

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.